We are live on ! Find out more
KA

Kintegral Advisory Portfolio holdings

AUM $1.06B
1-Year Est. Return 24.93%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$493M
AUM Growth
+$18.1M
Cap. Flow
-$74.3K
Cap. Flow %
-0.02%
Top 10 Hldgs %
27.09%
Holding
269
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$74.3K

Sector Composition

Rank Sector Weight
1 Technology 26.46%
2 Healthcare 14.85%
3 Financials 14.08%
4 Communication Services 10.72%
5 Industrials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
76
Cardinal Health
CAH
$51.7B
$1.99M 0.4%
41,756
– –
MDLZ icon
77
Mondelez International
MDLZ
$78.1B
$1.94M 0.39%
35,804
– –
HPQ icon
78
HP
HPQ
$23B
$1.88M 0.38%
89,787
– –
BMY icon
79
Bristol-Myers Squibb
BMY
$124B
$1.84M 0.37%
40,508
– –
C icon
80
Citigroup
C
$222B
$1.81M 0.37%
25,909
– –
ADP icon
81
Automatic Data Processing
ADP
$97.2B
$1.8M 0.36%
10,829
– –
NSC icon
82
Norfolk Southern
NSC
$74.3B
$1.79M 0.36%
8,979
– –
CSX icon
83
CSX Corp
CSX
$92.8B
$1.74M 0.35%
67,563
– –
CME icon
84
CME Group
CME
$90.1B
$1.72M 0.35%
8,853
– –
BIIB icon
85
Biogen
BIIB
$29.2B
$1.7M 0.34%
7,260
– –
CB icon
86
Chubb
CB
$133B
$1.68M 0.34%
11,340
– –
BDX icon
87
Becton Dickinson
BDX
$42.2B
$1.67M 0.34%
6,772
– –
XEL icon
88
Xcel Energy
XEL
$50.1B
$1.63M 0.33%
27,170
– –
BNY
89
Bank of New York Mellon
BNY
$109B
$1.63M 0.33%
36,839
– –
CELG
90
DELISTED
Celgene Corp
CELG
$1.6M 0.32%
17,299
– –
HCA icon
91
HCA Healthcare
HCA
$82.5B
$1.58M 0.32%
11,708
– –
TRV icon
92
Travelers Companies
TRV
$77.6B
$1.5M 0.3%
10,041
– –
TT icon
93
Trane Technologies
TT
$105B
$1.5M 0.3%
11,828
– –
CL icon
94
Colgate-Palmolive
CL
$73.3B
$1.5M 0.3%
20,870
– –
STT icon
95
State Street
STT
$50.9B
$1.49M 0.3%
26,432
– –
ABT icon
96
Abbott
ABT
$175B
$1.47M 0.3%
17,447
– –
IFF icon
97
International Flavors & Fragrances
IFF
$19.7B
$1.45M 0.29%
9,924
– –
PYPL icon
98
PayPal
PYPL
$49B
$1.42M 0.29%
12,390
– –
EW icon
99
Edwards Lifesciences
EW
$48.6B
$1.41M 0.29%
22,902
– –
SPGI icon
100
S&P Global
SPGI
$127B
$1.4M 0.28%
6,137
– –
2 3
4
5 6

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return

Kintegral Advisory's Q2 2019 Portfolio in Review

As of Q2 2019, Kintegral Advisory held 269 positions worth $493M, up 3.8% from $475M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Kintegral Advisory opened no new positions and made no exits, leaving the 269-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Kintegral Advisory's biggest Q2 2019 reduction was VF Corp, cutting an estimated $74.3K.
  • Kintegral Advisory's ten largest holdings make up 27% of its $493M portfolio in Q2 2019.
  • Kintegral Advisory opened 0 new positions and closed 0 in Q2 2019.
  • Kintegral Advisory's portfolio value rose 3.8% quarter-over-quarter to $493M.

Based on Kintegral Advisory's 13F filing for Q2 2019, filed 13 Aug 2019.